The Dividend Dilemma: A Tale of Two Pharma Giants The pharmaceutical sector is abuzz with excitement over dividend growth stories, none more tantalizing than those of Amgen and Merck.
These two industry stalwarts are vying for investors' attention with their respective dividend yields and payout histories. Amgen stands out from the crowd, boasting a quarterly dividend of $2.
52 per share, an annualized forward payout of $10. 08, and a yield of approximately 2. 6%. This is significantly more attractive than Merck's $0. 85 quarterly payout, which yields a mere 2. 29%.